Table 1.
Characteristics of patients at baseline
| Characteristics | No of patients (n = 108) |
|---|---|
| Age, y; median (range) | 67 (37‐87) |
| Sex (male/ female) | 70/38 |
| ECOG performance status, n (%) | |
| 0 | 17 (15.8) |
| 1 | 53 (49.1) |
| 2 | 25 (23.1) |
| Unknown | 13 (12.0) |
| Smoking status, n (%) | |
| Current | 34 (31.5) |
| Former | 62 (57.4) |
| Never | 4 (3.7) |
| Unknown | 8 (7.4) |
| Histology, n (%) | |
| Squamous | 28 (25.9) |
| Non squamous | 80 (74.1) |
| Mutations, n (%) | |
| KRAS | 18 (16.6) |
| BRAF | 4 (3.7) |
| MET | 3 (2.7) |
| ROS1 | 1 (0.9) |
| Brain metastasis, n (%) | |
| Yes | 19 (17.6) |
| No | 89 (82.4) |
| Stage, n (%) | |
| III | 14 (13.0) |
| IV | 94 (87.0) |